Dr Nikhil Tandon of AIIMS, Delhi, described self-administering and self-titrating doses as a terrible idea, noting that clinical trials always pair these drugs with exercise and dietary guidance
The finding suggests that the effects of GLP-1s could be extended, potentially reducing how often these drugs must be administered
Bridging clinical gaps: Multi-dataset integration for reliable multi-class lung disease classification with DeepCRINet and occlusion sensitivity
Inborn errors of metabolism identified via newborn screening: Ten-year incidence data and costs of nutritional interventions for research agenda planning
[13] Such dosing is intended to reverse life-threatening seizures and metabolic effects by restoring adequate coenzyme levels
Adults with type 2 diabetes, a body mass index (BMI) of 30 or above, or a BMI of 27 or above with health-related complications such as high blood pressure and sleep apnea might consider treatment with a GLP-1 medication
